United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 21130-062_4650a28b-d299-a5e5-e063-6294a90ad9f7
- Product NDC
- 21130-062
- Form
- TABLET
- Composition / generic term
- Naproxen
- Labeler
- Safeway, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230830
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 50 TABLET in 1 BOTTLE (21130-062-05) · 21130-062-05
- 90 TABLET in 1 BOTTLE (21130-062-09) · 21130-062-09
- 200 TABLET in 1 BOTTLE (21130-062-20) · 21130-062-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →